Report of Foreign Issuer (6-k)
October 28 2016 - 2:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2016
Commission File Number: 001-15152
SYNGENTA AG
(Translation of registrant’s name into
English)
Schwarzwaldallee 215
4058 Basel
Switzerland
(Address of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Re: SYNGENTA
AG
Disclosure:
“ChemChina
transaction: update on regulatory process”
Herewith we furnish a press release
related to Syngenta AG. The full text of the press release is the following:
# # #
Syngenta International AG
Media Office
CH-4002 Basel
Switzerland
Tel: +41 61 323 2323
Fax: +41 61 323 2424
www.syngenta.com
|
Media contacts:
Leandro Conti
Switzerland +41 61 323 2323
Paul Minehart
USA +1 202 737 8913
|
Analyst/Investor contacts:
Jennifer Gough
Switzerland +41 61 323 5059
USA +1 202 737 6521
|
Basel, Switzerland,
October 28, 2016
ChemChina transaction: update
on regulatory process
Syngenta
and ChemChina today announced that the EU review of ChemChina’s acquisition of Syngenta will enter Phase II with effect
from 31 October. The regular duration of Phase II is up to 90 working days. The companies intend to continue constructive discussions
with the EU authorities in order to conclude the review as early as possible.
About
Syngenta
Syngenta
is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of
available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working
to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing
rural communities. To learn more visit
www.syngenta.com
and
www.goodgrowthplan.com
.
Follow us on Twitter
®
at
www.twitter.com/Syngenta
.
Additional
information and where to find it
This release
is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell company
securities. The solicitation and offer to buy company securities will only be made pursuant to the Swiss offer prospectus
and the offer to purchase and other documents relating to the U.S. offer that have been filed with the U.S. Securities and Exchange
Commission ("SEC"). investors and security holders are urged to carefully read the tender offer statement on schedule
to filed by the offeror with the SEC and the solicitation/recommendation statement on schedule 14d-9 with respect to the offer
filed by the company with the SEC, since these materials contain important information, including the terms and conditions of
the offer. Investors and security holders may obtain a free copy of these materials and other documents filed by the offeror and
the company with the SEC at the website maintained by the SEC at www.sec.gov. Investors and security holders may also obtain
free copies of the solicitation/recommendation statement and other documents filed with the SEC by the company at www.syngenta.com.
Syngenta –October 28, 2016 / Page
1
of 2
Cautionary statement regarding forward-looking
statements
Some of the statements contained in this
release are forward-looking statements, including statements regarding the expected consummation of the Swiss and U.S. public tender
offers, which involves a number of risks and uncertainties, including the satisfaction of closing conditions for the offers, such
as regulatory approval for the transaction and the tender of at least 67% of the outstanding shares of the company, the possibility
that the transaction will not be completed and other risks and uncertainties discussed in the company’s public filings with
the SEC, including the “risk factors” section of the company’s form 20-f filed on February 11, 2016, as well
as the tender offer documents filed by the offeror and the solicitation/recommendation statement filed by the company. These
statements are based on current expectations, assumptions, estimates and projections, and involve known and unknown risks, uncertainties
and other factors that may cause results, levels of activity, performance or achievements to be materially different from any future
statements. These statements are generally identified by words or phrases such as “believe”, “anticipate”,
“expect”, “intend”, “plan”, “will”, “may”, “should”, “estimate”,
“predict”, “potential”, “continue” or the negative of such terms or other similar expressions.
If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results and the timing of events
may differ materially from the results and/or timing discussed in the forward-looking statements, and you should not place undue
reliance on these statements. The offeror, ChemChina and the company disclaim any intent or obligation to update any forward-looking
statements as a result of developments occurring after the period covered by this release or otherwise.
Syngenta –October 28, 2016 / Page
2
of 2
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
SYNGENTA AG
|
Date:
|
October 28, 2016
|
|
By:
|
/s/
Tobias Meili
|
|
|
|
|
Name:
|
Dr.
Tobias Meili
|
|
|
|
|
Title:
|
Head Corporate Legal Affairs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Markus Widmer
|
|
|
|
|
Name:
|
Markus Widmer
|
|
|
|
|
Title:
|
Legal Counsel
|
|
|
|
|
|
|
Syngenta (NYSE:SYT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Syngenta (NYSE:SYT)
Historical Stock Chart
From Aug 2023 to Aug 2024